63
Participants
Start Date
April 30, 2016
Primary Completion Date
January 10, 2019
Study Completion Date
January 10, 2019
CYP2D6
Gentic testing for CYP2D6 metabolic pathway will be performed at baseline.
Brief Pain Inventory-Short Form (BPI-SF)
This questionnaire will be completed at baseline and weeks 2, 4, 6 and 8.
M.D. Anderson Symptom Inventory (MDASI)
This questionnaire will be completed at baseline and weeks 2, 4, 6 and 8.
OPRM1
Genetic testing of the OPRM1 will be performed after week 8.
University of Florida, Gainesville
H. Lee Moffitt Cancer Center & Research Institute, Tampa
University of Florida
OTHER